'We strong­ly dis­sent': Women biotech ex­ecs pen let­ter to col­leagues and politi­cians in Roe v. Wade af­ter­math

In the days fol­low­ing the US Supreme Court’s roll­back of fed­er­al abor­tion rights, more than  100 women biotech ex­ec­u­tives came to­geth­er in an open let­ter to con­demn the rul­ing and tell their fel­low drug de­vel­op­ment lead­ers that they “will not stand by silent­ly.”

Ad­dressed to in­dus­try, friends, leg­is­la­tors and elect­ed of­fi­cials, the biotech ex­ec­u­tives said they were join­ing “the re­sound­ing mil­lions in cho­rus” by show­ing their “pro­found dis­may and dis­ap­point­ment” at the de­ci­sion hand­ed down by SCO­TUS last week, a re­ver­sal of Roe v. Wade that had been an­tic­i­pat­ed for weeks fol­low­ing a court leak.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.